Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Condition(s):B Acute Lymphoblastic LeukemiaLast Updated:February 20, 2024Suspended
Hide Studies Not Open or Pending
Condition(s):B Acute Lymphoblastic LeukemiaLast Updated:February 20, 2024Suspended
Condition(s):Mental Health; Substance-Related DisordersLast Updated:September 22, 2023Enrolling by invitation
Condition(s):Lung Adenocarcinoma; Lung Adenosquamous Carcinoma; Lung Non-Small Cell Carcinoma; Stage IIIB Lung Cancer AJCC v8; Stage IIIC Lung Cancer AJCC v8; Stage IV Lung Cancer AJCC v8Last Updated:March 27, 2024Recruiting
Condition(s):Acute Myeloid Leukemia; Myelodysplastic Syndrome; Myelodysplastic Syndrome/Acute Myeloid LeukemiaLast Updated:November 13, 2023Active, not recruiting
Condition(s):Stage IIIB Non-Small Cell Lung Cancer; Stage IV Non-small Cell Lung CancerLast Updated:May 6, 2023Terminated
Condition(s):Invasive Breast Carcinoma; Stage II Breast Cancer; Stage IIA Breast Cancer; Stage IIB Breast Cancer; Stage IIIA Breast CancerLast Updated:January 30, 2024Suspended
Condition(s):B Acute Lymphoblastic Leukemia; B Lymphoblastic LymphomaLast Updated:February 20, 2024Recruiting
Condition(s):Pancreatic Acinar Cell Carcinoma; Pancreatic Adenosquamous Carcinoma; Pancreatic Squamous Cell Carcinoma; Resectable Pancreatic Acinar Cell Carcinoma; Resectable Pancreatic Adenocarcinoma; Resectable Pancreatic Adenosquamous Carcinoma; Resectable Pancreatic CarcinomaLast Updated:March 21, 2024Recruiting
Condition(s):Clinical Stage III Cutaneous Melanoma AJCC v8; Clinical Stage IV Cutaneous Melanoma AJCC v8; Melanoma of Unknown Primary; Mucosal Melanoma; Unresectable Cutaneous Melanoma; Unresectable MelanomaLast Updated:March 6, 2024Active, not recruiting
Condition(s):Lumbar Spinal StenosisLast Updated:March 21, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.